Limited Competition: Continuation of the Preventing Early Renal Loss in Diabetes (PERL) Study (UC4)
Funding Opportunity ID: 290398 Opportunity Number: RFA-DK-16-506 Opportunity Title: Limited Competition: Continuation of the Preventing Early Renal Loss in Diabetes (PERL) Study (UC4)Opportunity Category: DiscretionaryOpportunity Category Explanation: Funding Instrument Type: Cooperative AgreementCategory of Funding Activity: Food and NutritionHealthCategory Explanation: CFDA Number(s): 93.847Eligible Applicants: State governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic and State controlled institutions of higher educationNative American...
Source: Grants.gov - December 2, 2016 Category: Research Tags: Food and Nutrition Health Source Type: funding

Limited Competition: Continuation of the Preventing Early Renal Loss in Diabetes (PERL) Study (UC4)
Funding Opportunity RFA-DK-16-506 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to complete treatment of the participants recruited into the Preventing Early Renal Loss in Diabetes (PERL) Study and to analyze the outcomes of the trial. PERL is a randomized, double-blind trial to test whether the medication, allopurinol, can slow the progression of kidney disease in people with type 1 diabetes and early diabetic kidney disease. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - December 1, 2016 Category: Research Source Type: funding